Brazil has confirmed greater than 330,000 circumstances of the coronavirus, surpassing Russia to grow to be the nation with the second-highest variety of infections, behind solely the USA.
The grim milestone on Friday got here because the World Well being Group (WHO) known as South America “a brand new epicentre” of the lethal virus, with the WHO’s emergencies director, Mike Ryan, expressing most concern for Brazil.
“In a way, South America has grow to be a brand new epicentre for the illness. We’ve seen many South American international locations with growing numbers of circumstances,” Ryan instructed a digital information convention.
“Clearly there’s a concern throughout lots of these international locations, however clearly essentially the most affected is Brazil at this level,” he stated.
Brazil registered 1,001 day by day coronavirus deaths on Friday, taking the whole deaths to 21,048, in accordance with the well being ministry.
Nonetheless the true quantity – of each circumstances and deaths – is probably going larger as Latin America’s high financial system has been sluggish to ramp up testing.
View of the intensive care unit treating COVID-19 coronavirus sufferers within the Gilberto Novaes Hospital in Manaus, Brazil [File: Michael Dantas/Reuters]
The demise toll has doubled in simply 11 days, in accordance with the ministry’s information. “Nearly all of the circumstances are from the Sao Paulo area,” Ryan stated.
“However when it comes to assault charges, the very best assault charges are literally in Amazonas: about 490 individuals contaminated per 100,000 inhabitants, which is kind of excessive,” he stated of Brazil’s huge northwestern state.
Brazil’s well being ministry has really helpful utilizing the anti-malarial medicine chloroquine and hydroxychloroquine to deal with even delicate circumstances of COVID-19 – therapies President Jair Bolsonaro has pushed for regardless of the shortage of conclusive proof of their effectiveness.
An evaluation revealed on Friday within the medical journal The Lancet discovered that sufferers handled with the medicine had the next threat of demise when put next with those that had not been given these medicines.
Ryan burdened that neither hydroxychloroquine nor chloroquine has been confirmed to be efficient within the therapy of COVID-19 – or in prophylaxis in opposition to the illness.
The 2 medicine are amongst a handful concerned in WHO-coordinated scientific trials to seek out efficient therapies for the illness. Some 3,000 sufferers are collaborating within the trials in 320 hospitals throughout 17 international locations.
“Our present scientific and systematic evaluations carried out by the Pan American Well being Group, and the present scientific proof, doesn’t assist the widespread use of hydroxychloroquine for the therapy of COVID-19 – not till the trials are accomplished and we now have clear outcomes,” stated Ryan.